Many of your patients are undergoing complicated, multiphase cancer treatments. We all need a basic understanding of what they are facing. Medscape Internal Medicine
Tag: Commentary
Leaving Your Legacy Via Death Bots? Ethicist Shares Concerns
Ethicist Art Caplan discusses using artificial intelligence to leave a digital legacy after death. Medscape Business of Medicine
Pickleball Rx: Serving Up Advice for Patients and Players
Falls are always a risk for athletes, particularly older people. But they can be prevented. Medscape Family Medicine
Disclose Ethics Consult to Patients? Ethicist Weighs In
Ethicist Art Caplan discusses whether doctors need to disclose ethics consults to patients or families. Medscape Business of Medicine
Dementia Deemed Highly Preventable: Here’s How
Newly identified modifiable risk factors add to what we already know about preventing or delaying dementia. Medscape Ob/Gyn
What ‘Project 2025’ Would Mean for Health and Healthcare
Excerpts from Project 2025 demonstrate the likely impact of sweeping changes to US healthcare policy. Medscape Internal Medicine
Why No Federal Ban on Copay Accumulators and Maximizers?
The US federal government refrains from enforcing bans on copay accumulators and maximizers for the American public, but it does ban them in its plan for federal workers. Why the double standard? Medscape Rheumatology
Sex, Marriage, Race, Education: 18 Years of Life Expectancy
Can a simple scoring system predict risk for death? Dr F. Perry Wilson discusses. Medscape
Understanding Sudden Unexpected Death in Epilepsy
Learn more about SUDEP, its risk factors, and the importance of epilepsy awareness and management. WebMD
Insurers’ Preauthorization Rules “Ethically Nuts”: Ethicist
Ethicist Art Caplan discusses the ethics of insurers’ rules and use of artificial intelligence in preauthorizing patients’ medical treatment. Medscape Business of Medicine
The LENS Trial: ‘Welcoming Back an Old Friend’
Akshay Jain, MD, and David Preiss, PhD, MRCP, discuss the results of the LENS trial which showed that fenofibrate slows diabetic retinopathy progression. Medscape Diabetes & Endocrinology
CRISPR and Stem Cells: New Hope in Retinitis Pigmentosa
Gene therapies for retinitis pigmentosa are advancing, with gene supplementation and CRISPR therapy at the forefront in the delivery of precision medicine, reports Dr Stephen Tsang. Medscape Ophthalmology
A Cash Giveaway to Improve Health
We can’t just give cash to low-income folks instead of food to improve their health, can we? That’s just what these researchers did. Medscape
Laboratory-Developed Meat: Ethicist Says It’s Worth Pursuing
Ethicist Art Caplan discusses considerations for laboratory-developed meat. Medscape Business of Medicine
Early Detection of MG May Lessen Symptom Severity
Early detection of myasthenia gravis, along with timely treatment, could mitigate symptom severity and optimize outcomes, reports Dr Nicholas Silvestri. Medscape Neurology
Be Alert for Conjunctivitis: New Human Cases of H5N1 Bird Flu
Clinicians should be aware of the symptoms of bird flu seen in the first few human cases. Medscape Internal Medicine
How Facial Temperature Reveals Age and Disease
Find out why Dr F. Perry Wilson says that the medical tricorder perhaps wasn’t as fanciful as it seemed when it was used by Dr Beverly Crusher on “Star Trek.” Medscape
Retinitis Pigmentosa: 5 Things to Know
Retinitis pigmentosa has a wide range of causes, may seriously affect quality of life, and could lead to blindness. These five things to know shed light on diagnosis and treatment. Medscape Ophthalmology
Online Diagnosis of STIs? Ethicist Says We Are Nowhere Close
Ethicist Art Caplan discusses the use of websites for diagnosing sexually transmitted diseases. Medscape Business of Medicine
Retinitis Pigmentosa: What’s New in Diagnosis and Treatment?
Dr Ninel Gregori reviews current retinitis pigmentosa diagnosis and treatment guidelines. Medscape Ophthalmology